WO2002046139A2 - Sels de 1,7- et de 1,9-diarylpolymethine - Google Patents
Sels de 1,7- et de 1,9-diarylpolymethine Download PDFInfo
- Publication number
- WO2002046139A2 WO2002046139A2 PCT/FR2001/003844 FR0103844W WO0246139A2 WO 2002046139 A2 WO2002046139 A2 WO 2002046139A2 FR 0103844 W FR0103844 W FR 0103844W WO 0246139 A2 WO0246139 A2 WO 0246139A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- compound
- group
- salt
- formula
- preparation
- Prior art date
Links
- 150000003839 salts Chemical class 0.000 title claims abstract description 113
- 150000001875 compounds Chemical class 0.000 claims abstract description 99
- -1 amino, hydrazono, hydrazino Chemical group 0.000 claims abstract description 45
- 125000001424 substituent group Chemical group 0.000 claims abstract description 17
- 125000004432 carbon atom Chemical group C* 0.000 claims abstract description 15
- 239000002253 acid Substances 0.000 claims abstract description 14
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 9
- 150000002367 halogens Chemical class 0.000 claims abstract description 9
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 claims abstract description 6
- 150000001450 anions Chemical class 0.000 claims abstract description 6
- 125000003739 carbamimidoyl group Chemical group C(N)(=N)* 0.000 claims abstract description 5
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 claims abstract description 5
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 4
- 239000001257 hydrogen Substances 0.000 claims abstract description 4
- 125000004435 hydrogen atom Chemical class [H]* 0.000 claims abstract description 4
- 238000000034 method Methods 0.000 claims description 46
- 238000002360 preparation method Methods 0.000 claims description 44
- GKASDNZWUGIAMG-UHFFFAOYSA-N triethyl orthoformate Chemical compound CCOC(OCC)OCC GKASDNZWUGIAMG-UHFFFAOYSA-N 0.000 claims description 35
- LWVVNNZRDBXOQL-AATRIKPKSA-O [(e)-3-(dimethylamino)prop-2-enyl]-dimethylazanium Chemical compound CN(C)\C=C\C[NH+](C)C LWVVNNZRDBXOQL-AATRIKPKSA-O 0.000 claims description 20
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 230000008569 process Effects 0.000 claims description 19
- QGKMIGUHVLGJBR-UHFFFAOYSA-M (4z)-1-(3-methylbutyl)-4-[[1-(3-methylbutyl)quinolin-1-ium-4-yl]methylidene]quinoline;iodide Chemical compound [I-].C12=CC=CC=C2N(CCC(C)C)C=CC1=CC1=CC=[N+](CCC(C)C)C2=CC=CC=C12 QGKMIGUHVLGJBR-UHFFFAOYSA-M 0.000 claims description 13
- 150000007857 hydrazones Chemical class 0.000 claims description 12
- 239000000203 mixture Substances 0.000 claims description 11
- 239000012429 reaction media Substances 0.000 claims description 10
- 239000003153 chemical reaction reagent Substances 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 125000000217 alkyl group Chemical group 0.000 claims description 7
- 150000001409 amidines Chemical class 0.000 claims description 7
- 150000002357 guanidines Chemical class 0.000 claims description 7
- 150000002429 hydrazines Chemical class 0.000 claims description 7
- ATAQLIDYIFWHFW-BQYQJAHWSA-N (e)-1,3,3-triethoxyprop-1-ene Chemical compound CCO\C=C\C(OCC)OCC ATAQLIDYIFWHFW-BQYQJAHWSA-N 0.000 claims description 6
- 150000001412 amines Chemical class 0.000 claims description 6
- 229910017464 nitrogen compound Inorganic materials 0.000 claims description 6
- 150000002830 nitrogen compounds Chemical class 0.000 claims description 6
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 6
- 150000004985 diamines Chemical class 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 238000001556 precipitation Methods 0.000 claims description 5
- JWUQFQYYMGMPKE-UHFFFAOYSA-N 2-chloro-3-(hydroxymethylidene)cyclohexene-1-carbaldehyde Chemical compound OC=C1CCCC(C=O)=C1Cl JWUQFQYYMGMPKE-UHFFFAOYSA-N 0.000 claims description 4
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical group [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims description 4
- 125000003277 amino group Chemical group 0.000 claims description 4
- 238000001035 drying Methods 0.000 claims description 4
- WFSXUTWNNVIIIG-ZPUQHVIOSA-N glutaconaldehyde Chemical compound O\C=C\C=C\C=O WFSXUTWNNVIIIG-ZPUQHVIOSA-N 0.000 claims description 4
- 125000000717 hydrazino group Chemical group [H]N([*])N([H])[H] 0.000 claims description 4
- 125000005638 hydrazono group Chemical group 0.000 claims description 4
- 125000001931 aliphatic group Chemical group 0.000 claims description 3
- 125000003545 alkoxy group Chemical group 0.000 claims description 3
- 238000001914 filtration Methods 0.000 claims description 3
- 125000004430 oxygen atom Chemical group O* 0.000 claims description 3
- 238000005406 washing Methods 0.000 claims description 3
- RXOKSCBSYXWODQ-UHFFFAOYSA-N 2-chloro-3-(hydroxymethylidene)cyclopentene-1-carbaldehyde Chemical compound OC=C1CCC(C=O)=C1Cl RXOKSCBSYXWODQ-UHFFFAOYSA-N 0.000 claims description 2
- WAGQOMWMROUWHS-UHFFFAOYSA-N 3-(hydroxymethylidene)cyclopentene-1-carbaldehyde Chemical compound OC=C1CCC(C=O)=C1 WAGQOMWMROUWHS-UHFFFAOYSA-N 0.000 claims description 2
- 150000001768 cations Chemical class 0.000 claims description 2
- 125000004185 ester group Chemical group 0.000 claims description 2
- 239000003550 marker Substances 0.000 claims description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 2
- 125000000467 secondary amino group Chemical group [H]N([*:1])[*:2] 0.000 claims 1
- 125000002091 cationic group Chemical group 0.000 abstract description 3
- 125000003118 aryl group Chemical group 0.000 abstract 1
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 69
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 37
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 34
- 238000005481 NMR spectroscopy Methods 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 21
- 229910052786 argon Inorganic materials 0.000 description 17
- OFBQJSOFQDEBGM-UHFFFAOYSA-N Pentane Chemical compound CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 14
- 239000000843 powder Substances 0.000 description 13
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- 230000015572 biosynthetic process Effects 0.000 description 11
- 238000002844 melting Methods 0.000 description 10
- 230000008018 melting Effects 0.000 description 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 9
- 238000000354 decomposition reaction Methods 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- RTILWBLRHGACAK-UHFFFAOYSA-N 1-hepta-1,3,6-trienyl-4-methylbenzene Chemical compound CC1=CC=C(C=C1)[CH+]C=CC=CC=C RTILWBLRHGACAK-UHFFFAOYSA-N 0.000 description 8
- PUAQLLVFLMYYJJ-UHFFFAOYSA-N 2-aminopropiophenone Chemical compound CC(N)C(=O)C1=CC=CC=C1 PUAQLLVFLMYYJJ-UHFFFAOYSA-N 0.000 description 8
- 238000004458 analytical method Methods 0.000 description 7
- 239000008188 pellet Substances 0.000 description 7
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 6
- KWOLFJPFCHCOCG-UHFFFAOYSA-N Acetophenone Chemical compound CC(=O)C1=CC=CC=C1 KWOLFJPFCHCOCG-UHFFFAOYSA-N 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- 238000002663 nebulization Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000000451 chemical ionisation Methods 0.000 description 5
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 0 CC(C)N(C(CC[C@](C)CCC(c1c(*)c(*)c(*)c(*)c1*)NC1CCCC1)c1c(*)c(*)c(*)c(*)c1*)C1CCCC1 Chemical compound CC(C)N(C(CC[C@](C)CCC(c1c(*)c(*)c(*)c(*)c1*)NC1CCCC1)c1c(*)c(*)c(*)c(*)c1*)C1CCCC1 0.000 description 4
- RGSFGYAAUTVSQA-UHFFFAOYSA-N Cyclopentane Chemical compound C1CCCC1 RGSFGYAAUTVSQA-UHFFFAOYSA-N 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 4
- 125000005594 diketone group Chemical group 0.000 description 4
- 239000000975 dye Substances 0.000 description 4
- 239000000706 filtrate Substances 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 4
- BHNHHSOHWZKFOX-UHFFFAOYSA-N 2-methyl-1H-indole Chemical class C1=CC=C2NC(C)=CC2=C1 BHNHHSOHWZKFOX-UHFFFAOYSA-N 0.000 description 3
- DZCCYLROHKTCLV-UHFFFAOYSA-N 4-[1,7-bis(4-methylphenyl)-7-morpholin-4-ium-4-ylidenehepta-1,3,5-trienyl]morpholine Chemical compound C1=CC(C)=CC=C1C(\N1CCOCC1)=C/C=C/C=C/C(C=1C=CC(C)=CC=1)=[N+]1CCOCC1 DZCCYLROHKTCLV-UHFFFAOYSA-N 0.000 description 3
- KHOITXIGCFIULA-UHFFFAOYSA-N Alophen Chemical compound C1=CC(OC(=O)C)=CC=C1C(C=1N=CC=CC=1)C1=CC=C(OC(C)=O)C=C1 KHOITXIGCFIULA-UHFFFAOYSA-N 0.000 description 3
- SEBMBOUGZQCTEP-UHFFFAOYSA-N CC1=CC=C(C=C1)[CH+]C=CC=CC=CC1=CC=C(C=C1)C Chemical compound CC1=CC=C(C=C1)[CH+]C=CC=CC=CC1=CC=C(C=C1)C SEBMBOUGZQCTEP-UHFFFAOYSA-N 0.000 description 3
- 238000010521 absorption reaction Methods 0.000 description 3
- 239000000090 biomarker Substances 0.000 description 3
- 239000000460 chlorine Substances 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 238000010586 diagram Methods 0.000 description 3
- 238000000921 elemental analysis Methods 0.000 description 3
- 238000007306 functionalization reaction Methods 0.000 description 3
- 125000000623 heterocyclic group Chemical group 0.000 description 3
- WVIICGIFSIBFOG-UHFFFAOYSA-N pyrylium Chemical compound C1=CC=[O+]C=C1 WVIICGIFSIBFOG-UHFFFAOYSA-N 0.000 description 3
- 239000000376 reactant Substances 0.000 description 3
- QWGFTGIQYCNGGH-UHFFFAOYSA-N 3,3,3-triethoxyprop-1-ene Chemical compound CCOC(OCC)(OCC)C=C QWGFTGIQYCNGGH-UHFFFAOYSA-N 0.000 description 2
- NZOFGTHQXJMBJT-UHFFFAOYSA-N 4-[(1e,3e,5e)-1,7-bis(4-methoxyphenyl)-7-morpholin-4-ium-4-ylidenehepta-1,3,5-trienyl]morpholine Chemical compound C1=CC(OC)=CC=C1C(\N1CCOCC1)=C/C=C/C=C/C(C=1C=CC(OC)=CC=1)=[N+]1CCOCC1 NZOFGTHQXJMBJT-UHFFFAOYSA-N 0.000 description 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 description 2
- HGINCPLSRVDWNT-UHFFFAOYSA-N Acrolein Chemical compound C=CC=O HGINCPLSRVDWNT-UHFFFAOYSA-N 0.000 description 2
- 239000004215 Carbon black (E152) Substances 0.000 description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 description 2
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 2
- 239000002262 Schiff base Substances 0.000 description 2
- 150000004753 Schiff bases Chemical class 0.000 description 2
- IYZPFJPKRARGRH-UHFFFAOYSA-N [(2e,4e,6z)-7-(diethylamino)-1,7-bis(4-methoxyphenyl)hepta-2,4,6-trienylidene]-diethylazanium Chemical compound C=1C=C(OC)C=CC=1/C(N(CC)CC)=C/C=C/C=C/C(=[N+](CC)CC)C1=CC=C(OC)C=C1 IYZPFJPKRARGRH-UHFFFAOYSA-N 0.000 description 2
- GJPAEICWLITCJH-UHFFFAOYSA-N [(2e,4e,6z)-7-(diethylamino)-1,7-bis(4-methylphenyl)hepta-2,4,6-trienylidene]-diethylazanium Chemical compound C=1C=C(C)C=CC=1/C(N(CC)CC)=C/C=C/C=C/C(=[N+](CC)CC)C1=CC=C(C)C=C1 GJPAEICWLITCJH-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- 239000006227 byproduct Substances 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000000295 emission spectrum Methods 0.000 description 2
- 238000000695 excitation spectrum Methods 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- DMEGYFMYUHOHGS-UHFFFAOYSA-N heptamethylene Natural products C1CCCCCC1 DMEGYFMYUHOHGS-UHFFFAOYSA-N 0.000 description 2
- 229930195733 hydrocarbon Natural products 0.000 description 2
- 150000002430 hydrocarbons Chemical class 0.000 description 2
- 125000001041 indolyl group Chemical group 0.000 description 2
- 125000001434 methanylylidene group Chemical group [H]C#[*] 0.000 description 2
- YCWSUKQGVSGXJO-NTUHNPAUSA-N nifuroxazide Chemical group C1=CC(O)=CC=C1C(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 YCWSUKQGVSGXJO-NTUHNPAUSA-N 0.000 description 2
- 239000012454 non-polar solvent Substances 0.000 description 2
- RUVINXPYWBROJD-UHFFFAOYSA-N para-methoxyphenyl Natural products COC1=CC=C(C=CC)C=C1 RUVINXPYWBROJD-UHFFFAOYSA-N 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 238000000163 radioactive labelling Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 238000004611 spectroscopical analysis Methods 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000002211 ultraviolet spectrum Methods 0.000 description 2
- FANCTJAFZSYTIS-IQUVVAJASA-N (1r,3s,5z)-5-[(2e)-2-[(1r,3as,7ar)-7a-methyl-1-[(2r)-4-(phenylsulfonimidoyl)butan-2-yl]-2,3,3a,5,6,7-hexahydro-1h-inden-4-ylidene]ethylidene]-4-methylidenecyclohexane-1,3-diol Chemical compound C([C@@H](C)[C@@H]1[C@]2(CCCC(/[C@@H]2CC1)=C\C=C\1C([C@@H](O)C[C@H](O)C/1)=C)C)CS(=N)(=O)C1=CC=CC=C1 FANCTJAFZSYTIS-IQUVVAJASA-N 0.000 description 1
- GDIYMWAMJKRXRE-UHFFFAOYSA-N (2z)-2-[(2e)-2-[2-chloro-3-[(z)-2-(1,3,3-trimethylindol-1-ium-2-yl)ethenyl]cyclohex-2-en-1-ylidene]ethylidene]-1,3,3-trimethylindole Chemical compound CC1(C)C2=CC=CC=C2N(C)C1=CC=C1C(Cl)=C(C=CC=2C(C3=CC=CC=C3[N+]=2C)(C)C)CCC1 GDIYMWAMJKRXRE-UHFFFAOYSA-N 0.000 description 1
- VIMMECPCYZXUCI-MIMFYIINSA-N (4s,6r)-6-[(1e)-4,4-bis(4-fluorophenyl)-3-(1-methyltetrazol-5-yl)buta-1,3-dienyl]-4-hydroxyoxan-2-one Chemical compound CN1N=NN=C1C(\C=C\[C@@H]1OC(=O)C[C@@H](O)C1)=C(C=1C=CC(F)=CC=1)C1=CC=C(F)C=C1 VIMMECPCYZXUCI-MIMFYIINSA-N 0.000 description 1
- ZYECOAILUNWEAL-NUDFZHEQSA-N (4z)-4-[[2-methoxy-5-(phenylcarbamoyl)phenyl]hydrazinylidene]-n-(3-nitrophenyl)-3-oxonaphthalene-2-carboxamide Chemical compound COC1=CC=C(C(=O)NC=2C=CC=CC=2)C=C1N\N=C(C1=CC=CC=C1C=1)/C(=O)C=1C(=O)NC1=CC=CC([N+]([O-])=O)=C1 ZYECOAILUNWEAL-NUDFZHEQSA-N 0.000 description 1
- IGVKWAAPMVVTFX-BUHFOSPRSA-N (e)-octadec-5-en-7,9-diynoic acid Chemical compound CCCCCCCCC#CC#C\C=C\CCCC(O)=O IGVKWAAPMVVTFX-BUHFOSPRSA-N 0.000 description 1
- JGVSIZVWGGQMPY-UHFFFAOYSA-N 1,3,3-trimethoxyprop-1-ene Chemical compound COC=CC(OC)OC JGVSIZVWGGQMPY-UHFFFAOYSA-N 0.000 description 1
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 1
- ZMDDOWQHSDJXDW-UHFFFAOYSA-N 2,3-dibromopropanal Chemical compound BrCC(Br)C=O ZMDDOWQHSDJXDW-UHFFFAOYSA-N 0.000 description 1
- NHUHYFRSGSQZIQ-UHFFFAOYSA-N 2-bromo-1,1,3-triethoxypropane Chemical compound CCOCC(Br)C(OCC)OCC NHUHYFRSGSQZIQ-UHFFFAOYSA-N 0.000 description 1
- YEKPNMQQSPHKBP-UHFFFAOYSA-N 2-methyl-6-nitrobenzoic anhydride Chemical compound CC1=CC=CC([N+]([O-])=O)=C1C(=O)OC(=O)C1=C(C)C=CC=C1[N+]([O-])=O YEKPNMQQSPHKBP-UHFFFAOYSA-N 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 1
- 125000006414 CCl Chemical group ClC* 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- GSNUFIFRDBKVIE-UHFFFAOYSA-N DMF Natural products CC1=CC=C(C)O1 GSNUFIFRDBKVIE-UHFFFAOYSA-N 0.000 description 1
- MYMOFIZGZYHOMD-UHFFFAOYSA-N Dioxygen Chemical compound O=O MYMOFIZGZYHOMD-UHFFFAOYSA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- PNDPGZBMCMUPRI-XXSWNUTMSA-N [125I][125I] Chemical compound [125I][125I] PNDPGZBMCMUPRI-XXSWNUTMSA-N 0.000 description 1
- YLEIFZAVNWDOBM-ZTNXSLBXSA-N ac1l9hc7 Chemical compound C([C@H]12)C[C@@H](C([C@@H](O)CC3)(C)C)[C@@]43C[C@@]14CC[C@@]1(C)[C@@]2(C)C[C@@H]2O[C@]3(O)[C@H](O)C(C)(C)O[C@@H]3[C@@H](C)[C@H]12 YLEIFZAVNWDOBM-ZTNXSLBXSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- HGCIXCUEYOPUTN-UHFFFAOYSA-N cis-cyclohexene Natural products C1CCC=CC1 HGCIXCUEYOPUTN-UHFFFAOYSA-N 0.000 description 1
- 238000010668 complexation reaction Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 238000004163 cytometry Methods 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 238000001215 fluorescent labelling Methods 0.000 description 1
- WBJINCZRORDGAQ-UHFFFAOYSA-N formic acid ethyl ester Natural products CCOC=O WBJINCZRORDGAQ-UHFFFAOYSA-N 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 239000008240 homogeneous mixture Substances 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 125000001810 isothiocyanato group Chemical group *N=C=S 0.000 description 1
- 230000000155 isotopic effect Effects 0.000 description 1
- 150000002678 macrocyclic compounds Chemical class 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000012544 monitoring process Methods 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 230000037361 pathway Effects 0.000 description 1
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 1
- 230000002285 radioactive effect Effects 0.000 description 1
- 230000009257 reactivity Effects 0.000 description 1
- 150000003335 secondary amines Chemical class 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 125000006850 spacer group Chemical group 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 125000004434 sulfur atom Chemical group 0.000 description 1
- AGGKEGLBGGJEBZ-UHFFFAOYSA-N tetramethylenedisulfotetramine Chemical compound C1N(S2(=O)=O)CN3S(=O)(=O)N1CN2C3 AGGKEGLBGGJEBZ-UHFFFAOYSA-N 0.000 description 1
- 125000003396 thiol group Chemical group [H]S* 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 108700012359 toxins Proteins 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
- C07D295/096—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/26—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring
- C07C211/28—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an unsaturated carbon skeleton containing at least one six-membered aromatic ring having amino groups linked to the six-membered aromatic ring by unsaturated carbon chains
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/62—Quaternary ammonium compounds
- C07C211/63—Quaternary ammonium compounds having quaternised nitrogen atoms bound to acyclic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/02—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C217/48—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
- C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
- C07C217/64—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains further substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/04—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C251/10—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton
- C07C251/16—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of an unsaturated carbon skeleton containing six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/02—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups
- C07C251/24—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton containing imino groups having carbon atoms of imino groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
- C07C251/86—Hydrazones having doubly-bound carbon atoms of hydrazone groups bound to carbon atoms of six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C251/00—Compounds containing nitrogen atoms doubly-bound to a carbon skeleton
- C07C251/72—Hydrazones
- C07C251/88—Hydrazones having also the other nitrogen atom doubly-bound to a carbon atom, e.g. azines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/164—Unsaturated ethers containing six-membered aromatic rings
- C07C43/166—Unsaturated ethers containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/03—Ethers having all ether-oxygen atoms bound to acyclic carbon atoms
- C07C43/14—Unsaturated ethers
- C07C43/17—Unsaturated ethers containing halogen
- C07C43/174—Unsaturated ethers containing halogen containing six-membered aromatic rings
- C07C43/176—Unsaturated ethers containing halogen containing six-membered aromatic rings having unsaturation outside the aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C43/00—Ethers; Compounds having groups, groups or groups
- C07C43/02—Ethers
- C07C43/20—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring
- C07C43/215—Ethers having an ether-oxygen atom bound to a carbon atom of a six-membered aromatic ring having unsaturation outside the six-membered aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/125—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
- C07D295/13—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
- C07D295/12—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
- C07D295/135—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/0066—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain being part of a carbocyclic ring,(e.g. benzene, naphtalene, cyclohexene, cyclobutenene-quadratic acid)
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B23/00—Methine or polymethine dyes, e.g. cyanine dyes
- C09B23/02—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups
- C09B23/08—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines
- C09B23/086—Methine or polymethine dyes, e.g. cyanine dyes the polymethine chain containing an odd number of >CH- or >C[alkyl]- groups more than three >CH- groups, e.g. polycarbocyanines more than five >CH- groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
- C07C2601/16—Systems containing only non-condensed rings with a six-membered ring the ring being unsaturated
Definitions
- the present invention relates to heptacarbonated or nonacarbonated carboxonium salts and streptocyanines, their preparation process, and their use as biological markers. 5 Chemical, chromatographic or spectroscopic methods have long been poorly suited to the detection of molecules in the field of nano and " subnanograms", for reasons of insufficient sensitivity.
- radioactive iodine 125 I
- endogenous and exogenous substances hormones, bacteria, viruses, toxins, etc.
- Cyanines are interesting compounds for coupling with biological molecules and can be used as markers because of their triple character: positively charged, lipophilic and fluorescent. It is known to use certain cyanines as
- ⁇ 5 markers in combination with antibodies, DNA, proteins, polysaccharides and other biological molecules, for the assay, in vivo and in vitro monitoring of active substances or for the diagnosis of various diseases. So that a compound can be used as
- the 30 biological marker it must have an absorption and emission domain moved towards the near infrared so as not to interfere with the autofluorescence zone of the substrate. It must also be able to be grafted onto the target molecule by covalent bond or by complexation.
- Cyanines which have five methine groups between the indole groups of ends) and which have a wavelength ⁇ max of the order of 680 nm has been described by the same authors. Cyanines of this type, called Cy5, are also sold by the company Amersham Life Science.
- the pentacarbonated carboxonium salt is obtained by reaction of an arylmethylketone with triethoxymethane and perchloric acid. This process is related
- streptocyanines obtained however have a wavelength ⁇ max which remains below a value of the order of 600 nm, which limits their use as a marker in the near infrared.
- the cyanines can be
- the first type of bisaldehyde is a glutaconaldehyde salt corresponding to the formula:
- the corresponding Schiff base corresponds to the formula:
- the second bisaldehyde is of the 2-Q-1-formyl-3-hydroxy ethylene cyclohexene type in which Q is most often
- the aim of the present invention is to provide new functionalized cyanines having a high absorption wavelength, which can be used in particular as markers.
- the subject of the invention is salts in which the cation comprises a group 1,7- or 1 / 9- . diarylpolymethine, as well as a process for their preparation, and their use as biological markers.
- a compound according to the invention corresponds to the following formula (I):
- n 0 or 1
- G and G 'independently of one another represent an OEt group, an amino group, a phosphaimino group, an amidino group, a guanidino group, a hydrazino group, a hydrazono group, or a multivalent radical linked to at least one of its other ends to a radical corresponding to formula (I 1 ) below
- G represents an OEt group, an amino group, a phosphaimino group, an amidino group, a guanidino group, a hydrazino group, a hydrazono group, or a multivalent radical;
- R 1 to R 5 independently of one another represent a hydrogen, a halogen, an alkyl radical, an alkyloxy radical having from 1 to 15 carbon atoms or an acetamido group CH 3 C (0) HN-;
- Z represents H or a halogen
- the anion is preferably chosen from BF 4 " , CF 3 S0 3 " , CIO4 ' , I " , Br “ and Cl " .
- G, G' or G" represents a multivalent radical, it is preferably chosen from -NH-E-NH- groups in which E is - (CH 2 ) n -, 3 ⁇ n ⁇ 9, or - (CH 2 ) 2 0 (CH 2 ) 2 0 (CH 2 ) 2 -.
- R 1 to R 7 , n, Q and Z have the meaning given above, and represents an ethyl group.
- n 0 and R 6 represents H, they correspond to the following formula (II A ).
- a compound (HA) according to the present invention can be prepared from an aryl ketone Ar-C (O) R '(hereinafter referred to as AC) in which Ar represents a phenyl radical bearing the substituents R 1 to R 5 defined above and R ′ S represents an alkyl radical having from 1 to 5 carbon atoms, preferably a methyl.
- TEM 1, 3, 3-triethoxypropene
- TEP 1, 3, 3-triethoxypropene
- the inert atmosphere is advantageously obtained by operating under argon.
- the process is preferably carried out at room temperature.
- the TEP / TEM ratio is preferably equal to 1 and the AC / TEM + TEP ratio is preferably equal to 1 to avoid the formation of by-products
- the strong acid is chosen from HBF 4 , CF 3 S0 3 H, HC10 4 , HI, HBr or HC1.
- the compound obtained in the reaction medium can be recovered by precipitation, filtering, washing and drying.
- the precipitation can be carried out in a solvent such as
- ⁇ 5 ether a hydrocarbon or a non-polar solvent.
- ethyl ether THF
- pentane hexane
- cyclohexane cyclopentane
- carbon tetrachloride a hydrocarbon or a non-polar solvent.
- the inventors found that, surprisingly, the addition of triethoxymethane to the reaction medium made it possible to obtain the expected compound (H A ), with the secondary product, the pyrylium salt (when TEM / TEP ⁇ 1) or the pentacarbonated carboxonium salt (when TEM / TEP> 1).
- Triethoxymethane is a commercially available compound under the name ethyl orthoformate.
- a compound (II B ) according to the present invention can be prepared from an aryl ketone ArC (O) R '(hereinafter referred to as AC) in which Ar represents a phenyl radical bearing the substituents R 1 to R 5 defined ci -above and R 'represent-
- Ar represents a phenyl radical bearing the substituents R 1 to R 5 defined ci -above and R 'represent-
- the process for the preparation of a compound (II B ) is characterized in that it consists in reacting ... aryl ketone (AC) with a mixture of triethoxymethane (TEM) and a bisaldehyde (BA) in presence of a strong acid,
- AC ... aryl ketone
- TEM triethoxymethane
- BA bisaldehyde
- CFHMCH 2-chloro-1-formyl-3-hydroxymethylenecyclohexene
- FHMCH l-formyl-3-hydroxymethylenecyclohexene
- CFHMCP 2-chloro-1-formyl-3-hydroxymethylenecyclopentene
- FHMCP 1-formyl-3-hydroxymethylenecyclopentene
- the inert atmosphere is advantageously obtained by operating under argon.
- the process is preferably carried out at room temperature.
- the BA / TEM ratio is preferably equal to 1/4 and the AC / TEM + BA ratio is preferably equal to 2/5 to limit the formation of undesirable by-products.
- the strong acid is chosen from HBF 4 , CF 3 S0 3 H, HC10 4 , HI, HBr or HC1.
- the compound (II B ) obtained in the reaction medium can be recovered by precipitation, filtering, washing and drying.
- the precipitation can be carried out in a solvent such as an ether, a hydrocarbon or a non-polar solvent.
- a solvent such as an ether, a hydrocarbon or a non-polar solvent.
- a compound according to the invention can also be a streptocyanine corresponding to formula (III) below:
- R B , R, R 10 and R 11 are chosen independently of each other from:
- - phenyl radicals optionally carrying substituents chosen independently of one another from H, halogens, alkyl or alkyloxy radicals having 1
- the heptacarbon streptocyanines of type (III) are represented by the following formula (III A ):
- the non-carbonaceous streptocyanines are represented by the following formula (III B ):
- a compound of the invention can also be a streptocyanine corresponding to the following formula (IV):
- R 1 to R 7 , n, Q and Z have the meaning given above -; • X and X 'independently of one another represent R “ 3 P, R" 2 N (R') C, (R “ 2 N) 2 C or NR" 2 , R "representing an alkyl preferably having from 1 to 4 carbon atoms, or a phenyl.
- the streptocyanines (IV) are symmetrical when the substituents X and X 'are identical.
- a heptacarbon streptocyanine of type (IV) is represented by the following formula (IV A ):
- a non-carbonaceous streptocyanine of type (IV) is represented by the following formula (IV B ):
- a compound of the present invention can also be D a macrocyclic dicationic compound corresponding to the following formula (V):
- R 1 to R 7 , n, Q and Z have the meaning given above
- a dicationic macrocyclic compound (V) in which each cationic group is heptacarbon corresponds to the following formula (V A ):
- a macrocyclic dicationic compound (V) in which each cationic group is nonacarbon corresponds to the following formula (V B ):
- a compound according to the invention may be a diaryl hemicarboxonium salt corresponding to the following formula (VI):
- a salt of type (VI) heptacarbone corresponds to the following formula (VI A ):
- a salt of the nonacarbon type (VI) corresponds to the following formula (VI B ):
- a compound according to the invention may also be a diaryl hemicarboxonium salt corresponding to the following formula (VII):
- a salt of type (VII) heptacarbone corresponds to the following formula (VH A ):
- a nonacarbon type salt (VII) corresponds to the following formula (VII B ):
- a compound according to the invention can also be a non-macrocyclic polycationic compound (VIII) when one of the substituents G or G 'is a multivalent group linked at each of its ends to a group corresponding to the formula (I') defined above .
- the process for the preparation of a symmetrical streptocyanine (III) of the invention consists in reacting a salt (H) with a nitrogenous compound, using at least two equivalents of nitrogenous compound for one equivalent of salt, said nitrogenous compound being chosen among amines, hydrazines and hydrazones.
- a heptacarbon salt (II A ) makes it possible to obtain a streptocyanine corresponding to the formula (III A ).
- a nonacarbon salt (II B ) makes it possible to obtain a streptocyanine corresponding to the formula (III B ).
- the process for the preparation of a symmetrical streptocyanine (IV) of the invention consists in reacting a compound (II) with a nitrogenous compound, using at least two equivalents of nitrogenous compound for an equivalent of salt, said nitrogenous compound being chosen among the guanidines, the phospha- imines and amidines.
- a heptacarbon salt (H A ) makes it possible to obtain a streptocyanine corresponding to the formula (IV A ).
- a nonacarbon salt (H B ) makes it possible to obtain a streptocyanine corresponding to the formula (IV B ).
- a macrocyclic dicationic compound (V) is obtained by reacting a compound (II) with a diamine H 2 NE-NH 2 , using a molar ratio (II) / diamine of 1/1.
- the use of a salt heptacarbone (H A) provides a streptocyanine of formula (V A).
- the use of a nonacarbon salt (II B ) makes it possible to obtain a streptocyanine corresponding to the formula (V B ).
- the process for preparing a hemicarboxonium salt (VI) or (VII) consists in reacting a compound (II) with a nitrogenous compound, using an equivalent of nitrogenous compound for an equivalent of compound (II).
- the nitrogenous compound is chosen from amines, hydrazines, hydrazones for a compound (VI) or from guanidines, phosphaimines and amidines for compounds (VII).
- the use of a heptacarbon salt (H A ) makes it possible to obtain a heptacarbon hemicarboxonium salt corresponding respectively to the formula (VI A ) or (VIIj).
- the use of a nonacarbon salt (H B ) makes it possible to obtain a nonacarbon hemicarboxonium salt corresponding respectively to the formula (VI B ) or (VII B ).
- a hemicarboxonium (VI) salt can advantageously be used for the preparation of asymmetric streptocyanines (III), by reaction of an equivalent of compound (VI) with an equivalent of a nitrogenous compound chosen from amines, hydrazines , hydrazones different from that used for the preparation of said compound (VI) from compound (II).
- a salt (VI A ) makes it possible to obtain an asymmetric cyanine (III A )
- a salt (VI B ) makes it possible to obtain an asymmetric streptocyanine (III B ).
- a hemicarboxonium salt (VII) can advantageously be used for the preparation of asymmetric streptocyanines (IV), by reaction of an equivalent of compound (VII) with an equivalent of a nitrogen compound chosen from guanidines, phosphaimines and the amidines different from that used for the preparation of said compound (VII) from compound (II).
- a salt (VII A ) allows to obtain an asymmetric streptocyanine (IV A )
- a salt (VH B ) allows to obtain an asymmetric streptocyanine (IV B ).
- a hemicarboxonium salt (VI) can also be used for the preparation of non macrocyclic dicationic compounds (VIII), by reaction of n equivalents of salt (VI) with an equivalent of a primary or secondary polyamine.
- n equivalents of salt (VI) with an equivalent of a primary or secondary polyamine.
- di-, tri-, tetra- or polycationic ' may be obtained by reacting two, three, four or n equivalents (n> 4) salt (VI) respectively with a diamine, a triamine, a tetramine or a polyamine.
- the hemicarboxonium (VI) salts can be grafted onto a substrate carrying nitrogenous functions, via the OEt function.
- the streptocyanines (III B ) of the invention in which Z is a halogen can be functionalized by replacing the halogen atom with a group -M- ⁇ -A. The compound then meets the formula
- M can be an oxygen or sulfur atom
- streptocyanines of the present invention corresponding to formulas (III), (IV), (VI) or (VII) can be advantageously used as markers for various biological molecules such as for example antibodies, DNA, proteins, polysaccharides .
- Another object of the present invention is a method for labeling biological molecules, characterized in that it uses a streptocyanine according to the present invention.
- the present invention is illustrated in more detail with the aid of a few examples to which it is not however limited.
- the bisaldehyde used in Example 14 is 2-chloro-1-formyl-3-hydroxymethylenecyclohexene CFHMCH. It was prepared according to the method described by GA Reynolds, KH Drexhage, J. Org. Chem. 1977, 42, 885. This is a simple reaction, fast, and implementing the 'DMF, dichloromethane, cyclohexanone and the oxide ID trichlorophosphore all of which are commercial reagents.
- the summary diagram is summarized as follows:
- Bisaldehyde CFHMCH is in the form of an orange-yellow crystalline powder. Its characteristics are as follows:
- Example 3 The procedure described in Example 3 was used for the preparation of compound 2a, but using the compound lb obtained in Example 2.
- the compound corresponding to the following formula was obtained in the form of pink crystals , with a yield of 73%.
- salt 3a was thus isolated in the form of purple flakes with blue-green reflections, with a yield of 56%. It corresponds to the following formula:
- Salt 5a was thus isolated in the form of a green-blue powder, with a yield of 12%.
- salt la was dissolved in about 50 ml of dry acetonitrile.
- An equivalent of diethylamine (0.11 ml / 1.08 mmol) was then added. After twelve hours of reaction, the acetonitrile was evaporated. The residue was washed with pentah and then dried under vacuum. Salt 6a corresponding to the following formula was isolated in the form of an orange-red powder.
- Example 10 The procedure described in Example 10 was used for the preparation of compound 6a, but using the compound lb obtained in Example 2.
- the compound corresponding to the following formula was obtained in the form of a 5 shiny black powder, with a yield of 92%.
- hemicarboxonium salt 7a was dissolved in 15 ml of dry acetonitrile. 0.04 ml
- Salt 8a corresponding to the following formula, was thus isolated, in the form of a dark blue crystalline powder, with a yield of 37%.
- the characteristics of the diketonic compound (9a ′) are the following:
- IR (KBr pellet)
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP01999551A EP1339671A2 (fr) | 2000-12-07 | 2001-12-05 | Sels de 1,7- et de 1,9-diarylpolymethine |
US10/433,890 US20040054178A1 (en) | 2000-12-07 | 2001-12-05 | 1,7, and 1,9-diarylpolymethine salts |
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0015928A FR2817862B1 (fr) | 2000-12-07 | 2000-12-07 | Nouveaux sels de 1,7-diarylpentamethine |
FR00/15928 | 2000-12-07 | ||
FR01/09743 | 2001-07-20 | ||
FR0109743A FR2827597B1 (fr) | 2001-07-20 | 2001-07-20 | Sels de 1,9-diarylheptamethine |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2002046139A2 true WO2002046139A2 (fr) | 2002-06-13 |
WO2002046139A3 WO2002046139A3 (fr) | 2002-08-01 |
Family
ID=26212766
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2001/003844 WO2002046139A2 (fr) | 2000-12-07 | 2001-12-05 | Sels de 1,7- et de 1,9-diarylpolymethine |
Country Status (3)
Country | Link |
---|---|
US (1) | US20040054178A1 (fr) |
EP (1) | EP1339671A2 (fr) |
WO (1) | WO2002046139A2 (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013012886A1 (fr) * | 2011-07-18 | 2013-01-24 | Georgia State University Research Foundation, Inc. | Carbocyanines pour la stabilisation de l'adn g-quadruplexe et inhibition de la télomérase |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1229319A (fr) * | 1967-08-11 | 1971-04-21 | ||
EP0119831A2 (fr) * | 1983-03-15 | 1984-09-26 | Minnesota Mining And Manufacturing Company | Système coloré blanchissable par la chaleur |
WO2000053678A1 (fr) * | 1999-03-11 | 2000-09-14 | Dyomics | Colorants marqueurs proches de l'infrarouge (nir) compatibles aux lasers |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5661139A (en) * | 1995-01-13 | 1997-08-26 | Alteon Inc. | Bis-(2-aryl) hydrazones |
US6815133B2 (en) * | 2002-04-12 | 2004-11-09 | Samsung Electronics Co., Ltd. | Sulfonyldiphenylene based charge transport compositions |
-
2001
- 2001-12-05 US US10/433,890 patent/US20040054178A1/en not_active Abandoned
- 2001-12-05 WO PCT/FR2001/003844 patent/WO2002046139A2/fr not_active Application Discontinuation
- 2001-12-05 EP EP01999551A patent/EP1339671A2/fr not_active Withdrawn
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB1229319A (fr) * | 1967-08-11 | 1971-04-21 | ||
EP0119831A2 (fr) * | 1983-03-15 | 1984-09-26 | Minnesota Mining And Manufacturing Company | Système coloré blanchissable par la chaleur |
WO2000053678A1 (fr) * | 1999-03-11 | 2000-09-14 | Dyomics | Colorants marqueurs proches de l'infrarouge (nir) compatibles aux lasers |
Non-Patent Citations (2)
Title |
---|
CHEMICAL ABSTRACTS, vol. 72, no. 25, 22 juin 1970 (1970-06-22) Columbus, Ohio, US; abstract no. 132188, MAKIN, S. M. ET AL: "Unsaturated ethers. XXXI. Condensation of.beta.-ethoxyacrolein acetal with vinylalkyl ethers and 1-alkoxydienes. New method for synthesizing cyanine compounds" XP002172472 & ZH. ORG. KHIM. (1970), 6(3), 455-9 , 1970, * |
PAYRASTRE C ET AL: "A synthetic pathway to macrocyclic and optically active pentamethinium salts" TETRAHEDRON LETTERS, ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL, vol. 35, no. 19, 1994, pages 3059-3562, XP002172471 ISSN: 0040-4039 * |
Also Published As
Publication number | Publication date |
---|---|
WO2002046139A3 (fr) | 2002-08-01 |
US20040054178A1 (en) | 2004-03-18 |
EP1339671A2 (fr) | 2003-09-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0180492B1 (fr) | Complexes macropolycycliques de terres rares-et application à titre de marqueurs fluorescents | |
EP1848725B1 (fr) | Dipyrromethenes-bore borocarbones insatures | |
US7598385B2 (en) | Asymmetric cyanine fluorescent dyes | |
US8753570B2 (en) | Structure, synthesis, and applications for oligo phenylene ethynylenes | |
FR2978149A1 (fr) | Nouveaux agents complexants et complexes de lanthanide correspondant, et leur utilisation comme marqueurs luminescents | |
EP1912921A2 (fr) | Composes a base de tetraazaporphyrine et leurs utilisations | |
US9040704B2 (en) | Fluorescent dyes with large stokes shifts | |
EP2684881B1 (fr) | Composé fluorescent, capteur de concentration d'ion comprenant le composé, réactif comprenant le composé, coffret de réactif comportant le réactif, et procédé de synthèse du composé | |
FR2989377A1 (fr) | Fluorophores organiques emettant a l'etat solide | |
Ayari et al. | 3-Methylindole-substituted zinc phthalocyanines for photodynamic cancer therapy | |
FR2934595A1 (fr) | Reactifs de marquage ayant un noyau pyridine portant une fonction diazomethyle, procedes de synthese de tels reactifs et procedes de detection de molecules biologiques | |
WO2002046139A2 (fr) | Sels de 1,7- et de 1,9-diarylpolymethine | |
CN102040530A (zh) | 生物分子的功能化方法 | |
US8710220B2 (en) | Synthesis of 8-amino boron dipyrromethenes having blue fluorescence | |
JP5749921B2 (ja) | C60−ポルフィリン共有結合体 | |
WO2019211568A1 (fr) | Procede de synthese de molecules aromatiques fluorees en presence d'un photocatalyseur | |
JP6249210B2 (ja) | 有機蛍光材料 | |
Nguyen et al. | Investigation of isomerism in anthracene-isothiouronium salts and application of these salts for anion sensing | |
EP2758391B1 (fr) | Sondes luminescentes pour le marquage biologique et l'imagerie, et leur procédé de préparation. | |
EP0396435A1 (fr) | Dérivés polyazotés et leurs complexes métalliques utilisables pour la fixation de l'oxygène | |
FR2817862A1 (fr) | Nouveaux sels de 1,7-diarylpentamethine | |
EP1430036A1 (fr) | Nouveau procede de preparation de macrocycles azotes c-fonctionnalises et nouveaux intermediaires obtenus | |
US20180208775A1 (en) | New aromatic macrocyclic metal complex dyes and the synthesis thereof with active nano metal powders | |
FR2827597A1 (fr) | Sels de 1,9-diarylheptamethine | |
JP4511125B2 (ja) | フェニルアゾメチンデンドリマーとデンドロン誘導体の合成方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
AK | Designated states |
Kind code of ref document: A3 Designated state(s): JP US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A3 Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2001999551 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 10433890 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 2001999551 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |
|
WWW | Wipo information: withdrawn in national office |
Ref document number: 2001999551 Country of ref document: EP |